Stock Updates

A look at a High Market Cap Stock: Eli Lilly and Company, LLY

Eli Lilly and Company, LLY is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in USA, Eli Lilly and Company, LLY  has a market cap of 87374.32. Since its IPO date on the 6/1/1972, Eli Lilly and Company, LLY performance year to date is -5.03%. Today Eli Lilly and Company, LLY has gained 0.36%, with a current price of 78.72.

Ownership of the company is 11.40% for insider ownership while institutional ownership is 77.10%. The management of the company have seen the company have a payout ratio of 91.20%. Return of assets are at 6.90%, with return on investment at 9.50%.

In terms of debt levels and profit levels, Eli Lilly and Company, LLY is seeing a long-term debt/equity of 0.59. While Total debt/equity is 0.64. With a profit margin of 12.00%, this is combined with a gross margin of 73.70%, and operating margin of 14.60%. Eli Lilly and Company ability to meet debt levels, with a current ratio of 1.5, while the quick ratio is 1.1.

For the last year Eli Lilly and Company, LLY has seen a EPS growth of 1.60%. A performance for the year of 2.90%. The 52-week high is -12.96%, and the 52-week low is 17.49%. The average volume for Eli Lilly and Company, LLY is 1131806.

With a target price of 96.7, can Eli Lilly and Company, LLY reach this target? Looking at the value indicators of Eli Lilly and Company, LLY. Eli Lilly and Company has a P/E of 33.81 and a forward P/E of 19.18. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.59. Eli Lilly and Company also has a P/S and a P/B of 4.24 and 5.67 respectively. For P/cash, Eli Lilly and Company has a value of 22.21, while it is *TBA for P/free cash flow.

At the current price of 78.72, Eli Lilly and Company has a dividend yield of 2.60%. We see a return on equity of 16.60%.

Looking more long-term Eli Lilly and Company, is projected to get an EPS growth for the next five years of 13.06%. In the short-term an EPS growth of 13.99% in the next year is forecasted. This is after a EPS growth of 1.60% for this year and for the last five years a -13.20% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment